Cargando…
P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429023/ http://dx.doi.org/10.1097/01.HS9.0000968516.29905.4e |
_version_ | 1785090611879084032 |
---|---|
author | Chantepie, Sylvain Huguet, Françoise Hunault, Mathilde Roth Guepin, Gabrielle Balsat, Marie Pilar Gallego Hernanz, Maria Joris, Magalie Karangwa, Alexandre Ojeda Uribe, Mario Santagostino, Alberto Maury, Sébastien |
author_facet | Chantepie, Sylvain Huguet, Françoise Hunault, Mathilde Roth Guepin, Gabrielle Balsat, Marie Pilar Gallego Hernanz, Maria Joris, Magalie Karangwa, Alexandre Ojeda Uribe, Mario Santagostino, Alberto Maury, Sébastien |
author_sort | Chantepie, Sylvain |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104290232023-08-17 P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY Chantepie, Sylvain Huguet, Françoise Hunault, Mathilde Roth Guepin, Gabrielle Balsat, Marie Pilar Gallego Hernanz, Maria Joris, Magalie Karangwa, Alexandre Ojeda Uribe, Mario Santagostino, Alberto Maury, Sébastien Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429023/ http://dx.doi.org/10.1097/01.HS9.0000968516.29905.4e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Chantepie, Sylvain Huguet, Françoise Hunault, Mathilde Roth Guepin, Gabrielle Balsat, Marie Pilar Gallego Hernanz, Maria Joris, Magalie Karangwa, Alexandre Ojeda Uribe, Mario Santagostino, Alberto Maury, Sébastien P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY |
title | P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY |
title_full | P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY |
title_fullStr | P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY |
title_full_unstemmed | P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY |
title_short | P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY |
title_sort | p402: inotuzumab ozogamicin treatment in adult patients with relapsed or refractory philadelphia chromosome-negative cd22-positive b-cell precursor acute lymphoblastic leukemia: a real-life french study |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429023/ http://dx.doi.org/10.1097/01.HS9.0000968516.29905.4e |
work_keys_str_mv | AT chantepiesylvain p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy AT huguetfrancoise p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy AT hunaultmathilde p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy AT rothguepingabrielle p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy AT balsatmarie p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy AT pilargallegohernanzmaria p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy AT jorismagalie p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy AT karangwaalexandre p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy AT ojedauribemario p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy AT santagostinoalberto p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy AT maurysebastien p402inotuzumabozogamicintreatmentinadultpatientswithrelapsedorrefractoryphiladelphiachromosomenegativecd22positivebcellprecursoracutelymphoblasticleukemiaareallifefrenchstudy |